Reports for SANOFI-AVENTIS CANADA INC
Company Name
SANOFI-AVENTIS CANADA INC
Totals |
||
Shortage reports |
283 |
|
| Actual shortage: | 5 (2%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 16 (6%) | |
| Resolved: | 262 (93%) | |
Discontinuation Reports |
50 |
|
| To be discontinued: | 6 (12%) | |
| Discontinued: | 44 (88%) | |
| Reversed: | 0 (0%) | |
Late reports |
21 (6%) |
|
Overdue reports |
4 (36%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AVALIDE | 12.5MG 150MG | TABLET | Resolved | 2018-12-20 | 2019-02-27 | 70230 |
| AVALIDE | 12.5MG 150MG | TABLET | Resolved | 2019-10-09 | 2020-01-24 | 95800 |
| AVALIDE | 150MG 12.5MG | TABLET | Resolved | 2021-01-28 | 2021-03-20 | 132678 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-02-08 | 2019-03-02 | 75166 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-05-08 | 2019-05-10 | 83440 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-07-16 | 2020-01-24 | 89482 |
| AVALIDE | 12.5MG 300MG | TABLET | Avoided shortage | 2022-04-14 | 2022-08-11 | 158890 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2022-08-11 | 2022-08-11 | 166530 |
| AUBAGIO | 14MG | TABLET | Resolved | 2022-04-25 | 2022-05-04 | 159348 |
| ARAVA | 20MG | TABLET | Resolved | 2019-11-29 | 2020-04-25 | 100066 |
| ARAVA | 20MG | TABLET | Resolved | 2020-11-16 | 2020-12-02 | 128414 |
| ARAVA | 10MG | TABLET | Resolved | 2019-11-29 | 2020-04-25 | 100069 |
| ARAVA | 10MG | TABLET | Resolved | 2022-08-02 | 2023-01-27 | 165914 |
| ARAVA | 10MG | TABLET | Resolved | 2023-07-19 | 2023-11-28 | 199224 |
| ARAVA | 20MG | TABLET | Resolved | 2023-02-15 | 2023-06-14 | 184712 |
| APIDRA | 100UNIT | SOLUTION | Resolved | 2019-11-26 | 2020-01-28 | 99690 |
| APIDRA | 100UNIT | SOLUTION | Resolved | 2021-05-06 | 2021-05-12 | 138831 |
| APIDRA | 100UNIT | SOLUTION | Resolved | 2022-10-07 | 2023-07-12 | 171433 |
| APIDRA | 100UNIT | SOLUTION | Avoided shortage | 2019-11-26 | 2019-11-26 | 99685 |
| APIDRA | 100UNIT | SOLUTION | Resolved | 2022-08-26 | 2022-09-14 | 168019 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NOVAHISTEX DH | 20MG 5MG | SYRUP | Discontinued | 2019-11-11 | 2020-08-04 | 98374 |
| MYOCHRYSINE | 10MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86067 |
| MYOCHRYSINE | 25MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86070 |
| MYOCHRYSINE | 50MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86073 |
| LIBTAYO | 250MG | SOLUTION | Discontinued | 2023-12-06 | 2023-12-09 | 212566 |
| KEVZARA | 150MG | SOLUTION | Discontinued | 2022-07-12 | 2022-08-02 | 164491 |
| JEVTANA | 40MG | SOLUTION | Discontinued | 2023-06-21 | 2023-09-13 | 196086 |
| IMOVANE | 5.0MG | TABLET | To be discontinued | 2022-05-16 | 2022-05-16 | 160688 |
| FLAGYL | 500MG | CAPSULE | Discontinued | 2023-03-22 | 2023-03-22 | 187634 |
| FLAGYL | 10% | CREAM | To be discontinued | 2024-03-28 | 2024-03-28 | 223877 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57608 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57613 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57616 |
| DIABETA | 2.5MG | TABLET | Discontinued | 2019-12-11 | 2020-08-04 | 100935 |
| DIABETA | 5MG | TABLET | Discontinued | 2019-12-11 | 2020-08-04 | 100938 |
| DEMEROL | 50MG | TABLET | Discontinued | 2019-11-11 | 2020-07-29 | 98380 |
| CONDYLINE | 0.5% | SOLUTION | To be discontinued | 2021-07-13 | 2021-07-13 | 142368 |
| CLOMID | 50MG | TABLET | Discontinued | 2017-03-22 | 2017-03-22 | 3917 |
| CLAFORAN - PWS INJ 2.0G/VIAL | 2G | POWDER FOR SOLUTION | Discontinued | 2017-03-20 | 2017-04-05 | 3685 |
| CLAFORAN - PWS INJ 1.0G/VIAL | 1G | POWDER FOR SOLUTION | Discontinued | 2017-03-16 | 2017-05-02 | 3103 |